Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W W Fleischhacker

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
Schizophrenia Research|July 31, 1999
T-cell subsets in schizophrenia: a comparison between drug-naive first episode patients and chronic schizophrenic patientsB Sperner-Unterweger, A Whitworth, G Kemmler, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 15, 2015
Hostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studiesJ Volavka, R A Van Dorn, L Citrome, et al.
Psychopharmacology|March 1, 1996
Does eosinophilia predict clozapine induced neutropenia?M Hummer, B Sperner-Unterweger, G Kemmler, et al.
Acta Psychiatrica Scandinavica|October 1, 1992
The effects of alcohol and benzodiazepines on the severity of ski accidentsC Barnas, C H Miller, G Sperner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 28, 2000
Further evidence that behavioral tests and neuropeptide mRNA and tissue level alterations can differentiate between typical and atypical antipsychotic drugsR Bauer, A Mayr, W Lederer, et al.
Psychopharmacology Bulletin|January 1, 1995
A comparison of European and American dosing regimens of schizophrenic patients on clozapine: efficacy and side effectsS Pollack, J A Lieberman, W W Fleischhacker, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 25, 2015
Differential effects of antipsychotic drugs on insight in first episode schizophrenia: Data from the European First-Episode Schizophrenia Trial (EUFEST)G H M Pijnenborg, M E Timmerman, E M Derks, et al.
Neuroscience|May 30, 2001
Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatmentJ Marksteiner, U Weiss, C Weis, et al.
Biological Psychiatry|June 1, 1996
CSF of neuroleptic-naive first-episode schizophrenic patients: levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin)C Miller, R Kirchmair, J Troger, et al.
European Journal of Haematology|August 31, 2000
EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparisonM Kopp, H Schweigkofler, B Holzner, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Schizophrenia Research|July 31, 1999
T-cell subsets in schizophrenia: a comparison between drug-naive first episode patients and chronic schizophrenic patientsB Sperner-Unterweger, A Whitworth, G Kemmler, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 15, 2015
Hostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studiesJ Volavka, R A Van Dorn, L Citrome, et al.
Psychopharmacology|March 1, 1996
Does eosinophilia predict clozapine induced neutropenia?M Hummer, B Sperner-Unterweger, G Kemmler, et al.
Acta Psychiatrica Scandinavica|October 1, 1992
The effects of alcohol and benzodiazepines on the severity of ski accidentsC Barnas, C H Miller, G Sperner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 28, 2000
Further evidence that behavioral tests and neuropeptide mRNA and tissue level alterations can differentiate between typical and atypical antipsychotic drugsR Bauer, A Mayr, W Lederer, et al.
Psychopharmacology Bulletin|January 1, 1995
A comparison of European and American dosing regimens of schizophrenic patients on clozapine: efficacy and side effectsS Pollack, J A Lieberman, W W Fleischhacker, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 25, 2015
Differential effects of antipsychotic drugs on insight in first episode schizophrenia: Data from the European First-Episode Schizophrenia Trial (EUFEST)G H M Pijnenborg, M E Timmerman, E M Derks, et al.
Neuroscience|May 30, 2001
Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatmentJ Marksteiner, U Weiss, C Weis, et al.
Biological Psychiatry|June 1, 1996
CSF of neuroleptic-naive first-episode schizophrenic patients: levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin)C Miller, R Kirchmair, J Troger, et al.
European Journal of Haematology|August 31, 2000
EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparisonM Kopp, H Schweigkofler, B Holzner, et al.
Pageof 13